2,4,6-trihydroxybenzaldehyde has been researched along with 3-o-methylgallic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forester, SC; Waterhouse, AL | 1 |
| Choy, YY; Forester, SC; Oteiza, PI; Waterhouse, AL | 1 |
2 other study(ies) available for 2,4,6-trihydroxybenzaldehyde and 3-o-methylgallic acid
| Article | Year |
|---|---|
Gut metabolites of anthocyanins, gallic acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde, inhibit cell proliferation of Caco-2 cells.
Topics: Anthocyanins; Apoptosis; Benzaldehydes; Caco-2 Cells; Cell Proliferation; Gallic Acid; Humans | 2010 |
The anthocyanin metabolites gallic acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde decrease human colon cancer cell viability by regulating pro-oncogenic signals.
Topics: Anthocyanins; Apoptosis; Benzaldehydes; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Colonic Neoplasms; Dose-Response Relationship, Drug; Gallic Acid; Humans; NF-kappa B; Organic Cation Transporter 1; Signal Transduction; STAT1 Transcription Factor; Transcription Factor AP-1 | 2014 |